Sexual dysfunction after simultaneous pancreas-kidney transplantation.

Area of Science:

• Transplantation Medicine
• Urology
• Endocrinology

Background:

• Simultaneous pancreas-kidney transplantation (SPK) is a primary treatment for type 1 diabetes mellitus and end-stage renal disease (ESRD).
• Patient-reported outcomes, including quality of life (QoL), are increasingly important in transplant care.
• The effect of erectile dysfunction (ED) on QoL in SPK recipients remains understudied.

Purpose of the Study:

• To determine the prevalence and severity of ED after SPK.
• To assess the impact of ED on the quality of well-being (QWB) in male SPK recipients.
• To explore the relationship between ED, QoL, and pre-existing comorbidities.

Main Methods:

• Utilized the International Index of Erectile Function (IIEF) to assess ED in 101 male SPK recipients.
• Categorized patients based on IIEF scores to determine ED prevalence and severity.
• Compared the Quality of Well-being (QWB) index across different ED severity groups.

Main Results:

• Only 21% of patients reported no ED; significant prevalence across mild to severe categories was observed.
• Forty-one percent noted improvement in ED post-transplant, while 51% reported no change.
• A significant inverse correlation was found between ED severity and QWB scores.

Conclusions:

• Erectile dysfunction is prevalent among SPK recipients and negatively impacts their quality of life.
• ED severity directly affects patient well-being, independent of transplant status.
• Vascular comorbidities may confound the relationship between ED and QoL in this population.